Difference between revisions of "Team:UCLouvain/OurProject/Overview"

 
(16 intermediate revisions by 5 users not shown)
Line 21: Line 21:
 
</div>
 
</div>
  
<p>Although sunburns seem  quite ordinary to get tanned , it’s a real disaster for our skin… Indeed, for several years, our exposure  to UV rays has increased and scientists have noticed an upward trend in risks of developing skin cancers.</p>
+
<p>Although sunburns seem  quite ordinary to get tanned, it’s a real disaster for our skin… Indeed, for several years, our exposure  to UV rays has increased and scientists have noticed an upward trend in the risk of developing skin cancers.</p>
<p>Every year in Belgium we count approximately <b>2.000 new cases of melanoma</b> (CHU de Liège).</p>
+
<p>Every year in Belgium we count approximately <b>2.000 new cases of melanoma</b> [1].</p>
<p>Between 2005 and 2015 in Belgium, there has been a <b>77% increase of new cases of melanoma</b> (Belgian Cancer Registry).</p>
+
<p>Between 2005 and 2015 in Belgium, there has been a <b>77% increase of new cases of melanoma</b> [2].</p>
 
 
 
<img src="https://static.igem.org/mediawiki/2017/8/8b/UCLouvain_Overview3.png" class="in_text_img" style="width: 500px;">
 
<img src="https://static.igem.org/mediawiki/2017/8/8b/UCLouvain_Overview3.png" class="in_text_img" style="width: 500px;">
  
<p>According to the WHO, there are  globally around <b>2 to 3 million skin cancers</b> each year, and around <b>132.000 melanoma</b> (World Health Organization).</p>
+
<p>According to WHO, there are  globally around <b>2 to 3 million skin cancers</b> each year, and around <b>132.000 melanoma</b> [3].</p>
 
<p>One American out of  five will develop a skin cancer in his lifetime. We are all affected by this dangerous problem, but some people with specific characteristics are much more concerned.</p>
 
<p>One American out of  five will develop a skin cancer in his lifetime. We are all affected by this dangerous problem, but some people with specific characteristics are much more concerned.</p>
 
</div>
 
</div>
Line 35: Line 35:
 
<div class="col-md-12">
 
<div class="col-md-12">
 
<div class="section-title" style="text-align:center;float:left;width:100%;margin-bottom:0">
 
<div class="section-title" style="text-align:center;float:left;width:100%;margin-bottom:0">
<span>bactasun</span>
+
<span>Our solution : <Marine style="margin-left:32px;font-family:'Brush Script MT';font-size:44px;text-transform:none;font-weight:bold;">BactaSun</Marine></span>
 
<p/p>
 
<p/p>
 
</div>
 
</div>
  
<p>That’s the reason why we, the 2017 UCLouvainiGEM Team, are participating in the international competition of synthetic biology, iGEM.</p>
+
<p>That’s the reason why we, the 2017 UCLouvain iGEM Team, are participating in the international competition of synthetic biology, iGEM.</p>
<p>Our innovative solution is BactaSun, a bio-badge changing color when exposed to UV rays.Its color gradually switches when exposed to UV rays. In a nutshell, you are quickly warned when you have to protect your skin.</p>
+
<p>Our innovative solution is BactaSun, a bio-badge changing color when exposed to UV rays. Its color gradually switches from white to red. In a nutshell, you are quickly warned when you have to protect your skin.</p>
  
 
<img src="https://static.igem.org/mediawiki/2017/9/9d/UCLouvain_Overview1.png" class="in_text_img" style="width: 500px;">
 
<img src="https://static.igem.org/mediawiki/2017/9/9d/UCLouvain_Overview1.png" class="in_text_img" style="width: 500px;">
  
 
<p>Actually, we have developed <b>two ways</b> to achieve our goal. Both are using a photocaged amino acid, the ONB-Tyrosine. The cage, the ONB group, is cleaved when exposed to UV rays, which releases the tyrosine amino acid, making it available for protein synthesis (see on the figure below).</p>
 
<p>Actually, we have developed <b>two ways</b> to achieve our goal. Both are using a photocaged amino acid, the ONB-Tyrosine. The cage, the ONB group, is cleaved when exposed to UV rays, which releases the tyrosine amino acid, making it available for protein synthesis (see on the figure below).</p>
+
<figure>
 
<img src="https://static.igem.org/mediawiki/2017/a/a3/UCLouvain_Overview2.png" class="in_text_img" style="width: 500px;">
 
<img src="https://static.igem.org/mediawiki/2017/a/a3/UCLouvain_Overview2.png" class="in_text_img" style="width: 500px;">
 +
<figcaption> <center> <font size = "2"><i> The photo-uncaging of the ONB-Tyr (https://static.igem.org/mediawiki/2016/2/24/T--Aachen--onbtyrosincleavagereaction.png-modified)</i></font></figcaption>
 +
</figure>
 
</div>
 
</div>
 
</div>
 
</div>
 +
<div class="row" style="margin-bottom: 40px;">
 +
<div class="col-md-12">
 +
<div class="section-title" style="text-align:center;float:left;width:100%;margin-bottom:0">
 +
<span>Our Approaches...</span>
 +
<p/p>
 +
</div>
 +
</div>
 +
</div>
 +
  
 
<div class="row" style="margin-bottom: 40px;">
 
<div class="row" style="margin-bottom: 40px;">
Line 57: Line 68:
 
</div>
 
</div>
  
<p>Using the iGEM’s biobricks, we construct a plasmid containing a gene coding for a RFP. Arabinose activates this gene, thanks to its pBAD promoter.</p>
+
<p>Using the iGEM’s biobricks, we have assembled a plasmid containing a gene coding for a RFP. Arabinose activates this gene, thanks to its pBAD promoter.</p>
<p>On the other hand, we knocked out (KO) a gene required for tyrosine synthesis in E. coli, TyrA. A medium containing photo-caged tyrosine (Ortho Nitro Benzyl-Tyrosine) is used to grow the bacteria: this special tyrosine is sensitive to UV’s, and will be only available for our KO E. coli once uncaged.</p>
+
<p>On the other hand, we knocked out (KO) a gene required for tyrosine synthesis in <i>E. coli</i>, TyrA. A medium containing photocaged tyrosine (<i>ortho</i>-nitrobenzyl tyrosine) is used to grow the bacteria: this special tyrosine is sensitive to UVs, and will be only available for our KO <i>E. coli</i> once uncaged.</p>
 
 
 
<a href="https://2017.igem.org/Team:UCLouvain/Approach1" class="btn blue" style="float:right;"><span>learn more</span></a>
 
<a href="https://2017.igem.org/Team:UCLouvain/Approach1" class="btn blue" style="float:right;"><span>learn more</span></a>
Line 68: Line 79:
 
</div>
 
</div>
  
<p>ComS is a small peptide imported into the cytoplasm by the cell. Interacting with ComR, it will form a complex, that acts as a gene activator.</p>
+
<p>ComS is a small peptide imported into the cytoplasm by the cell. Interacting with ComR, it will form a complex acting as a gene activator.</p>
<p>ComS contains some tyrosine. Thanks to a collaboration with…, we synthetize ComS using the photo-caged Tyrosine instead of Tyrosine. This new ComS can’t interact with ComR, unless its Tyrosine have been uncaged by UV’s.</p>
+
<p>This peptide contains a tyrosine residue. Thanks to a collaboration with <a style="color:#0066cc;" href="https://www.deduveinstitute.be/people/vincent-stroobant">Vincent Stroobant</a>from the Institut de Duve, we synthetized a modified ComS involving a photocaged tyrosine. This new peptide shouldn't be able interact with ComR, unless its tyrosine has been uncaged by UVs.</p>
<p>The complex of ComR/ComS will simply activate a RFP gene, creating as previously a system responding to UV’s.</p>
+
<p>The ComR/ComS complex will simply activate a RFP gene, creating a system responding to UVAs.</p>
  
 
<a href="https://2017.igem.org/Team:UCLouvain/Approach2" class="btn blue" style="float:right;"><span>learn more</span></a>
 
<a href="https://2017.igem.org/Team:UCLouvain/Approach2" class="btn blue" style="float:right;"><span>learn more</span></a>
 
</div>
 
</div>
 
</div>
 
</div>
 
+
<br>
 +
<br>
 +
                     
 
<div class="row" style="margin-bottom: 40px;">
 
<div class="row" style="margin-bottom: 40px;">
 
<div class="col-md-12">
 
<div class="col-md-12">
 
<ul>
 
<ul>
<li style="font-style:italic;color:#999999;">Belgian Cancer Registry, n.d. Belgian Cancer Registry — Tableaux sur base annuelle [WWW Document]. URL http://www.kankerregister.org/Statistiques_tableaux%20annuelle (accessed 10.24.17).</li>
+
<li style="font-style:italic;color:#999999;"> [1] CHU de Liège, n.d. Le mélanome [WWW Document]. URL http://www.chu.ulg.ac.be/jcms/c_8187263/le-melanome (accessed 10.24.17).</li>
<li style="font-style:italic;color:#999999;">CHU de Liège, n.d. Le mélanome [WWW Document]. URL http://www.chu.ulg.ac.be/jcms/c_8187263/le-melanome (accessed 10.24.17).</li>
+
<li style="font-style:italic;color:#999999;"> [2] Belgian Cancer Registry, n.d. Belgian Cancer Registry — Tableaux sur base annuelle [WWW Document]. URL http://www.kankerregister.org/Statistiques_tableaux%20annuelle (accessed 10.24.17).</li>
<li style="font-style:italic;color:#999999;">World Health Organization, n.d. WHO | Skin cancers [WWW Document]. WHO. URL http://www.who.int/uv/faq/skincancer/en/ (accessed 10.24.17).</li>
+
<li style="font-style:italic;color:#999999;"> [3] World Health Organization, n.d. WHO | Skin cancers [WWW Document]. WHO. URL http://www.who.int/uv/faq/skincancer/en/ (accessed 10.24.17).</li>
 
</ul>
 
</ul>
 
</div>
 
</div>
Line 87: Line 100:
 
</div>
 
</div>
 
</section>
 
</section>
 +
</html>
 
{{UCLouvainFooter}}
 
{{UCLouvainFooter}}

Latest revision as of 12:02, 1 November 2017

iGEM UCLouvain Team iGEM UCLouvain Team

Our Project

BactaSun Overview
the issue

Although sunburns seem quite ordinary to get tanned, it’s a real disaster for our skin… Indeed, for several years, our exposure to UV rays has increased and scientists have noticed an upward trend in the risk of developing skin cancers.

Every year in Belgium we count approximately 2.000 new cases of melanoma [1].

Between 2005 and 2015 in Belgium, there has been a 77% increase of new cases of melanoma [2].

According to WHO, there are globally around 2 to 3 million skin cancers each year, and around 132.000 melanoma [3].

One American out of five will develop a skin cancer in his lifetime. We are all affected by this dangerous problem, but some people with specific characteristics are much more concerned.

Our solution : BactaSun

That’s the reason why we, the 2017 UCLouvain iGEM Team, are participating in the international competition of synthetic biology, iGEM.

Our innovative solution is BactaSun, a bio-badge changing color when exposed to UV rays. Its color gradually switches from white to red. In a nutshell, you are quickly warned when you have to protect your skin.

Actually, we have developed two ways to achieve our goal. Both are using a photocaged amino acid, the ONB-Tyrosine. The cage, the ONB group, is cleaved when exposed to UV rays, which releases the tyrosine amino acid, making it available for protein synthesis (see on the figure below).

The photo-uncaging of the ONB-Tyr (https://static.igem.org/mediawiki/2016/2/24/T--Aachen--onbtyrosincleavagereaction.png-modified)
Our Approaches...

1. Auxotrophic

Using the iGEM’s biobricks, we have assembled a plasmid containing a gene coding for a RFP. Arabinose activates this gene, thanks to its pBAD promoter.

On the other hand, we knocked out (KO) a gene required for tyrosine synthesis in E. coli, TyrA. A medium containing photocaged tyrosine (ortho-nitrobenzyl tyrosine) is used to grow the bacteria: this special tyrosine is sensitive to UVs, and will be only available for our KO E. coli once uncaged.

learn more
2. Com R/S

ComS is a small peptide imported into the cytoplasm by the cell. Interacting with ComR, it will form a complex acting as a gene activator.

This peptide contains a tyrosine residue. Thanks to a collaboration with Vincent Stroobantfrom the Institut de Duve, we synthetized a modified ComS involving a photocaged tyrosine. This new peptide shouldn't be able interact with ComR, unless its tyrosine has been uncaged by UVs.

The ComR/ComS complex will simply activate a RFP gene, creating a system responding to UVAs.

learn more


  • [1] CHU de Liège, n.d. Le mélanome [WWW Document]. URL http://www.chu.ulg.ac.be/jcms/c_8187263/le-melanome (accessed 10.24.17).
  • [2] Belgian Cancer Registry, n.d. Belgian Cancer Registry — Tableaux sur base annuelle [WWW Document]. URL http://www.kankerregister.org/Statistiques_tableaux%20annuelle (accessed 10.24.17).
  • [3] World Health Organization, n.d. WHO | Skin cancers [WWW Document]. WHO. URL http://www.who.int/uv/faq/skincancer/en/ (accessed 10.24.17).
you think we're cool? so are our sponsors!
  • UCL
  • Fédération Wallonie Bruxelles
  • Fondation Louvain
  • Imperial College
  • Agilent Technologies
  • AGL
  • ISV
  • UCL faculté des Sciences